Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.
Ryo FujiwaraKentaro InamuraTakeshi YuasaNoboru NumaoShinya YamamotoHitoshi MasudaAkihiro KawauchiKengo TakeuchiJunji YonesePublished in: International journal of clinical oncology (2019)
Nivolumab has a relatively favorable efficacy and safety profile for Japanese metastatic renal cell cancer patients in clinical practice.